Bellicum Pharma (BLCM) Misses Q2 EPS by 4c

August 8, 2016 5:06 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Bellicum Pharma (NASDAQ: BLCM) reported Q2 EPS of ($0.61), $0.04 worse than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment